423 related articles for article (PubMed ID: 29569304)
1. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
[TBL] [Abstract][Full Text] [Related]
2. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
Filion LG; Matusevicius D; Graziani-Bowering GM; Kumar A; Freedman MS
Clin Immunol; 2003 Feb; 106(2):127-38. PubMed ID: 12672403
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
Wegner A; Verhagen J; Wraith DC
Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
[TBL] [Abstract][Full Text] [Related]
7. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
8. Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.
D'Amico E; Zanghì A; Parrinello NL; Romano A; Palumbo GA; Chisari CG; Toscano S; Raimondo FD; Zappia M; Patti F
Front Immunol; 2022; 13():819136. PubMed ID: 35273601
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
11. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
[TBL] [Abstract][Full Text] [Related]
12. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
[TBL] [Abstract][Full Text] [Related]
13. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
15. Monocyte-derived cytokines in multiple sclerosis.
Filion LG; Graziani-Bowering G; Matusevicius D; Freedman MS
Clin Exp Immunol; 2003 Feb; 131(2):324-34. PubMed ID: 12562396
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
Front Immunol; 2018; 9():1782. PubMed ID: 30123217
[TBL] [Abstract][Full Text] [Related]
17. Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells.
Soler DC; Young AB; Fiessinger L; Galimberti F; Debanne S; Groft S; McCormick TS; Cooper KD
J Invest Dermatol; 2016 Apr; 136(4):798-808. PubMed ID: 26807516
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.
Casacuberta-Serra S; Parés M; Golbano A; Coves E; Espejo C; Barquinero J
Immunol Cell Biol; 2017 Jul; 95(6):538-548. PubMed ID: 28108746
[TBL] [Abstract][Full Text] [Related]
19. CD14
Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
